Touyun Biotech Group (HKSE:01332) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:01332 Touyun Biotech Group Ltd HKSE:01332
20 GF Score
Price HK$0.14
GF Value HK$0.16
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Touyun Biotech Group Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Touyun Biotech Group Valuation Rank Related Terms

HKSE:01332
20GF Score
Touyun Biotech Group Ltd HKSE:01332
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Touyun Biotech Group (HKSE:01332) Overvalued in 2026?

Based on GuruFocus' analysis, Touyun Biotech Group stock appears to be undervalued. The current stock price of HK$0.14 is trading 15.6% below its estimated GF Value™ of HK$0.16. GuruFocus considers Touyun Biotech Group to be Modestly Undervalued.

Key valuation signals for HKSE:01332:

  • Valuation Rank:
  • GF Value™: HK$0.16 vs. price of HK$0.14 (15.6% below fair value)
  • GF Score™: 20/100 with 6 warning signs

No single metric tells the full story. See the HKSE:01332 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Touyun Biotech Group Business Description

Address 6 Tonnochy Road, 12th Floor, Kwan Chart Tower, Wanchai, Hong Kong, HKG
Touyun Biotech Group Ltd is principally engaged in the (i) the manufacture and sale of packaging products; (ii) investments and trading in securities and money lending, and (iii) production and sale of Chlamydomonas reinhardtii, micro-algae and related products. The company generates majority of its revenue from packaging products segment.
20GF Score

Get the complete analysis for HKSE:01332

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.14
Price
HK$0.16
GF Value